Onyx Biotec Limited IPO

NSE SME

Listed On: Nov 22, 2024 at ₹ 54.05

₹ 122000 /2000 Shares

Check Allotment

Onyx Biotec IPO Details

13 Nov, 2024

Open Date

18 Nov, 2024

Close Date

19 Nov, 2024

Allotment Date

22 Nov, 2024

Listing Date

Issue Price

₹58-61 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

NSE SME

Registrar

Mas Services Limited

List Price

54.05

Listing Date

2024-11-22

Market Lot

2000 Shares (₹122,000/-)

Lead Manager

Horizon Management Private Limited

Issue Size

4,810,000 shares(aggregating up to ₹29.34 Cr)

Retail Portion

35%

Subscription

198.68 times

IPO Docs

DRHP RHP

The IPO of Onyx Biotec is priced at ₹58-61 per equity share, which has a face value of ₹10 Per Equity Share each. The company shall list its equity shares on NSE SME. Mas Services Limited is the registrar of the issue.

Onyx Biotec IPO bid opening date is from Nov 13, 2024 and the bid closing date was Nov 18, 2024.
Onyx Biotec IPO allotment result will be available on Nov 19, 2024. The tentative listing date for Onyx Biotec is Nov 22, 2024.

The total issue size is 4,810,000 shares(aggregating up to ₹29.34 Cr).

As on	QIB / NII	Retail	Total
Shares Offered / Reserved	912,000 / 688,000	1,600,000	3,200,000
Day 1 - 13-11-24 06:00 PM	0.00 / 1.70 x	5.57 x	3.15 x
Day 2 - 14-11-24 06:00 PM	0.00 / 8.15 x	16.40 x	9.95 x
Day 3 - 18-11-24 06:00 PM	32.49 / 603.44 x	119.36 x	198.68 x

Total No. of Applications: 1,03,947 (Approx)

Onyx Biotec Valuations

EPS Pre IPO

₹2.28/-

EPS Post IPO

₹4.33/-

P/E Pre IPO

26.81

P/E Post IPO

14.1

ROE

4.99%

ROCE

3.71%

Debt/Equity

1.21

RoNW

4.99%

PAT Margin

12.42

Price to Book Value

3.10

Onyx Biotec Company Financials All values are in ₹ Lakh

	31-Mar-24	31-Mar-23	31-Mar-22
Assets	7,413.58	5,872.36	3,683.84
Revenue	5,387.43	3,961.65	4,498.09
Profit After Tax	303.16	184.46	335.29
Net Worth	2,487.87	1,820.16	1,637.59
Reserves & Surplus	1,155.65	1,230.00	1,047.43
Total Borrowing	3,078.04	2,922.83	1,224.39

About The Company

Incorporated in the month of May 2005, Onyx Biotec Limited is engaged in the field of pharmaceutical industry with sterile water for injections. The company, currently manufacturing Sterile Water for Injections is also a leading pharmaceutical contract manufacturer providing a holistic portfolio of Dry Powder Injections and Dry Syrups, both to domestic as well as international markets.

The company has two manufacturing units in Solan, Himachal Pradesh. Unit I has the daily production capacity of 638,889 units of Sterile Water for Injections and Unit II makes 40,000 units of dry powder injections and 26,667 units of dry syrup per day in a single shift.

Hetero Healthcare Limited, Mankind Pharma Limited, Sun Pharmaceutical Industries Limited, Aristo Pharmaceuticals Private Limited, Macleods Pharmaceuticals Limited, Mapra Laboratories Private Limited, Axa Parenterals Limited, FDC Limited, Zuventus Healthcare Limited, Akums Drugs and Pharmaceuticals Limited, Reliance Life Sciences Limited, among others are some of the clients for the company.

At the end of May 31, 2024, it had a clientele of over 100 Indian and multinational pharmaceutical companies.

ROHS Certification Private Limited has issued certificates for the management system, ISO 9001:2015 and ISO 14001:2015.

The company, as of July 31, 2024, employs 175 staff across the different departments.

Onyx Biotec - Promoter(s)

Pre Issue Share Holding: 88.60%

Post Issue Share Holding: %

Company Promoter(s)

Sanjay Jain
Naresh Kumar
Fateh Pal Singh

Onyx Biotec IPO - Issue Objectives

Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use
Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections
Prepayment or repayment of all or a portion of certain loans availed by the Company
General Corporate Purposes.

Other Details

Company Contact Details

Onyx Biotec

Bir Plassi Near Sainimajraropar, Nalagarh Road, District Solan – 174101

Phone: +91 172 265 6384

Email: generalinfo@onyxbiotec.com

Website: http://www.onyxbiotec.com/

Registrar Contact Details

Mas Services Limited

Phone: (011) 2610 4142

Email: ipo@masserv.com

Website: https://www.masserv.com/opt.asp

Onyx Biotec IPO - FAQs

Ans. Onyx Biotec Limited IPO is a SME IPO. The issue is priced at ₹58-61 per equity share. The minimum order quantity is 2000 Shares. The IPO opens on Nov 13, 2024, and closes on Nov 18, 2024. Mas Services Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Ans. The Onyx Biotec Limited IPO opens on Nov 13, 2024 and closes on Nov 18, 2024.

Ans. The size of Onyx Biotec Limited IPO is 4,810,000 shares(aggregating up to ₹29.34 Cr).

Ans. The IPO price band is set between ₹58-61 per equity share.

Ans. To apply for Onyx Biotec Limited IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Onyx Biotec Limited IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Onyx Biotec Limited IPO is Nov 19, 2024.

Ans. The Onyx Biotec Limited IPO will be listed on Nov 22, 2024.

Ans. Follow the steps to check the allotment status for Onyx Biotec Limited IPO here.